Evifacotrep is a selective TRPC5 channel antagonist, referenced in patent WO2020061162. It serves as a research tool for investigating neurological disorders, with applications in both in vitro and in vivo experimental models to study TRPC5-mediated signaling pathways.
Molekulargewicht:
441.77
Reinheit:
99.89% (May vary between batches)
CAS Nummer:
[2413739-88-3]
Formel:
C18H12ClF4N5O2
Target-Kategorie:
TRP/TRPV Channel
Anwendungsbeschreibung:
Solubility: DMSO:55 mg/mL (124.5 mM)
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten